Concepts (70)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthritis, Rheumatoid | 6 | 2020 | 251 | 1.220 |
Why?
|
| Protein Tyrosine Phosphatases | 2 | 2023 | 9 | 0.950 |
Why?
|
| Aggrecans | 4 | 2019 | 51 | 0.900 |
Why?
|
| Bone Development | 1 | 2023 | 30 | 0.780 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 4 | 2023 | 7 | 0.770 |
Why?
|
| Citrulline | 3 | 2019 | 6 | 0.670 |
Why?
|
| Epitopes | 3 | 2017 | 39 | 0.670 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 46 | 0.650 |
Why?
|
| Arthritis, Experimental | 2 | 2019 | 49 | 0.630 |
Why?
|
| Proteoglycans | 1 | 2016 | 120 | 0.490 |
Why?
|
| Thymocytes | 2 | 2023 | 2 | 0.410 |
Why?
|
| Animals | 7 | 2024 | 3301 | 0.400 |
Why?
|
| Mice | 4 | 2023 | 1241 | 0.400 |
Why?
|
| T-Lymphocytes | 2 | 2017 | 95 | 0.250 |
Why?
|
| GRB2 Adaptor Protein | 1 | 2023 | 1 | 0.200 |
Why?
|
| Chitosan | 1 | 2023 | 7 | 0.200 |
Why?
|
| Nanotubes | 1 | 2023 | 7 | 0.200 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2023 | 16 | 0.200 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2023 | 46 | 0.200 |
Why?
|
| X-Ray Microtomography | 1 | 2023 | 74 | 0.190 |
Why?
|
| Research Design | 1 | 2024 | 157 | 0.190 |
Why?
|
| Mice, Transgenic | 1 | 2023 | 176 | 0.190 |
Why?
|
| Signal Transduction | 2 | 2023 | 404 | 0.180 |
Why?
|
| Prosthesis-Related Infections | 1 | 2023 | 179 | 0.170 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2020 | 2 | 0.170 |
Why?
|
| Flow Cytometry | 2 | 2019 | 104 | 0.160 |
Why?
|
| B-Lymphocytes | 2 | 2019 | 51 | 0.160 |
Why?
|
| Azacitidine | 1 | 2019 | 11 | 0.150 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2019 | 14 | 0.150 |
Why?
|
| Enzyme Inhibitors | 1 | 2019 | 116 | 0.150 |
Why?
|
| Case-Control Studies | 2 | 2019 | 482 | 0.150 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2019 | 94 | 0.140 |
Why?
|
| DNA Methylation | 1 | 2019 | 129 | 0.140 |
Why?
|
| Vaccines | 1 | 2017 | 7 | 0.130 |
Why?
|
| Spleen | 1 | 2016 | 29 | 0.130 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 79 | 0.120 |
Why?
|
| Amino Acid Sequence | 1 | 2016 | 149 | 0.120 |
Why?
|
| Cell Proliferation | 1 | 2016 | 168 | 0.120 |
Why?
|
| Cytokines | 1 | 2016 | 213 | 0.120 |
Why?
|
| Cells, Cultured | 1 | 2016 | 481 | 0.120 |
Why?
|
| Cartilage, Articular | 1 | 2016 | 268 | 0.100 |
Why?
|
| Female | 2 | 2023 | 13149 | 0.080 |
Why?
|
| Humans | 5 | 2024 | 23355 | 0.070 |
Why?
|
| Male | 1 | 2023 | 12655 | 0.070 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 521 | 0.060 |
Why?
|
| Models, Animal | 1 | 2024 | 103 | 0.050 |
Why?
|
| Consensus | 1 | 2024 | 85 | 0.050 |
Why?
|
| Gentamicins | 1 | 2023 | 16 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2023 | 125 | 0.050 |
Why?
|
| Titanium | 1 | 2023 | 167 | 0.050 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2023 | 109 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2023 | 363 | 0.040 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2019 | 19 | 0.040 |
Why?
|
| Gene Silencing | 1 | 2019 | 23 | 0.040 |
Why?
|
| Autoimmune Diseases | 1 | 2019 | 26 | 0.040 |
Why?
|
| HLA-DRB1 Chains | 1 | 2019 | 2 | 0.040 |
Why?
|
| Autoantigens | 1 | 2019 | 15 | 0.040 |
Why?
|
| Autoantibodies | 1 | 2019 | 62 | 0.040 |
Why?
|
| Registries | 1 | 2019 | 176 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2017 | 96 | 0.030 |
Why?
|
| Complex Mixtures | 1 | 2016 | 3 | 0.030 |
Why?
|
| Tissue Extracts | 1 | 2016 | 8 | 0.030 |
Why?
|
| Antibody Specificity | 1 | 2016 | 19 | 0.030 |
Why?
|
| Arginine | 1 | 2016 | 17 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2016 | 60 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2016 | 133 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 339 | 0.030 |
Why?
|
| Osteoarthritis | 1 | 2016 | 279 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2017 | 2989 | 0.020 |
Why?
|
| Adult | 1 | 2016 | 7078 | 0.010 |
Why?
|